AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

PLUS THERAPEUTICS, INC. Director's Dealing 2018

Feb 1, 2018

34301_dirs_2018-02-01_dd5ba8af-5e51-4166-9e5f-356006ff95fa.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2018-01-25

Reporting Person: PostFinance AG (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5540054	Direct